Saul Faust
Coverage of Saul Faust in the Nexus archive.
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics
An AI-designed 'universal vaccine' targeting multiple coronaviruses has passed its first human clinical trial, showing safety and triggering an immune response in 39 volunteers. Developed by researchers from the Universities of Cambridge and Southampton, the vaccine uses a computer-simulated 'super-antigen' to combat evolving viruses, including those not yet discovered. The needle-free micro-fluid jet delivery method aims to simplify mass administration.
- First-ever AI-designed vaccine reaches human trials
A first-ever AI-designed vaccine targeting all coronaviruses and animal-borne strains has entered human trials. Initial safety tests with 39 participants succeeded, and larger efficacy studies are planned. The vaccine uses AI to create a 'super-antigen' for broad immunity, potentially reducing the need for frequent flu vaccine updates.